Transnational cancer research lab | Felsenstein Medical Research Center
PDF) Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects | Shlomit Perry, Ruth Pat-Horenczyk, Yuval Ziv, Salomon Stemmer, and Yaira Hamama-raz - Academia.edu
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
A genome‐wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi‐kinase inhibitors in hepatocellular carcinoma cells - Sofer - 2022 - The FASEB Journal - Wiley Online Library
Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single C
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Literature Scan - PORTAL: Program on Regulation, Therapeutics, and Law
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Staphylococcus Coagulase‐Positive Skin Inflammation Associated with Epidermal Growth Factor Receptor‐Targe
Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Pasireotide for malignant insulinoma
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic sol
